Gut Microbiome: Profound Implications for Diet and Disease
Tóm tắt
The gut microbiome plays an important role in human health and influences the development of chronic diseases ranging from metabolic disease to gastrointestinal disorders and colorectal cancer. Of increasing prevalence in Western societies, these conditions carry a high burden of care. Dietary patterns and environmental factors have a profound effect on shaping gut microbiota in real time. Diverse populations of intestinal bacteria mediate their beneficial effects through the fermentation of dietary fiber to produce short-chain fatty acids, endogenous signals with important roles in lipid homeostasis and reducing inflammation. Recent progress shows that an individual’s starting microbial profile is a key determinant in predicting their response to intervention with live probiotics. The gut microbiota is complex and challenging to characterize. Enterotypes have been proposed using metrics such as alpha species diversity, the ratio of Firmicutes to Bacteroidetes phyla, and the relative abundance of beneficial genera (e.g., Bifidobacterium, Akkermansia) versus facultative anaerobes (E. coli), pro-inflammatory Ruminococcus, or nonbacterial microbes. Microbiota composition and relative populations of bacterial species are linked to physiologic health along different axes. We review the role of diet quality, carbohydrate intake, fermentable FODMAPs, and prebiotic fiber in maintaining healthy gut flora. The implications are discussed for various conditions including obesity, diabetes, irritable bowel syndrome, inflammatory bowel disease, depression, and cardiovascular disease.
Từ khóa
Tài liệu tham khảo
Conlon, 2015, The impact of diet and lifestyle on gut microbiota and human health, Nutrients, 7, 17, 10.3390/nu7010017
Singh, 2017, Influence of diet on the gut microbiome and implications for human health, J. Transl. Med., 15, 73, 10.1186/s12967-017-1175-y
Brennan, 2016, Gut microbiota, inflammation, and colorectal cancer, Annu. Rev. Microbiol., 70, 395, 10.1146/annurev-micro-102215-095513
Valdes, 2018, Role of the gut microbiota in nutrition and health, BMJ, 361, k2179, 10.1136/bmj.k2179
Qin, 2010, A human gut microbial gene catalogue established by metagenomic sequencing, Nature, 464, 59, 10.1038/nature08821
Almeida, 2019, A new genomic blueprint of the human gut microbiota, Nature, 568, 499, 10.1038/s41586-019-0965-1
Rothschild, 2018, Environment dominates over host genetics in shaping human gut microbiota, Nature, 555, 210, 10.1038/nature25973
Noble, 2001, Waist-to-hip ratio versus BMI as predictors of cardiac risk in obese adult women, West. J. Med., 174, 240, 10.1136/ewjm.174.4.240-a
Hamer, 2017, Normal-Weight central obesity and risk for mortality, Ann. Intern. Med., 166, 917, 10.7326/L17-0022
Gentile, 2018, The gut microbiota at the intersection of diet and human health, Science, 362, 776, 10.1126/science.aau5812
Lauderdale, 2000, Body mass index in a US national sample of Asian Americans: Effects of nativity, years since immigration and socioeconomic status, Int. J. Obes., 24, 1188, 10.1038/sj.ijo.0801365
Vangay, 2018, US immigration westernizes the human gut microbiome, Cell, 175, 962, 10.1016/j.cell.2018.10.029
Wu, 2011, Linking long-term dietary patterns with gut microbial enterotypes, Science, 334, 105, 10.1126/science.1208344
Jonkers, 2015, Intestinal microbiota and diet in IBS: Causes, consequences, or epiphenomena?, Am. J. Gastroenterol., 110, 278, 10.1038/ajg.2014.427
Hall, 2017, A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients, Genome Med., 9, 103, 10.1186/s13073-017-0490-5
Henke, 2019, Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide, Proc. Natl. Acad. Sci. USA, 116, 12672, 10.1073/pnas.1904099116
Kim, 2014, Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis, World J. Gastroenterol., 20, 9872, 10.3748/wjg.v20.i29.9872
Jandhyala, 2015, Role of the normal gut microbiota, World J. Gastroenterol., 21, 8787, 10.3748/wjg.v21.i29.8787
Winter, 2014, Dysbiosis in the inflamed intestine: Chance favors the prepared microbe, Gut Microbes, 5, 71, 10.4161/gmic.27129
2014, Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity, World J. Gastrointest. Pathophysiol., 5, 213, 10.4291/wjgp.v5.i3.213
Lewis, 2015, Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn’s disease, Cell Host Microbe, 18, 489, 10.1016/j.chom.2015.09.008
Margolis, 2010, Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease, Am. J. Gastroenterol., 105, 2610, 10.1038/ajg.2010.303
Lloyd, 2004, Artificial nutrition: Principles and practice of enteral feeding, Clin. Colon Rectal Surg., 17, 107, 10.1055/s-2004-828657
Llewellyn, 2018, Interactions between diet and the intestinal microbiota alter intestinal permeability and colitis severity in mice, Gastroenterology, 154, 1037, 10.1053/j.gastro.2017.11.030
Chiba, 2010, Lifestyle-related disease in Crohn’s disease: Relapse prevention by a semi-vegetarian diet, World J. Gastroenterol., 16, 2484, 10.3748/wjg.v16.i20.2484
Lewis, 2017, Diet as a trigger or therapy for inflammatory bowel diseases, Gastroenterology, 152, 398, 10.1053/j.gastro.2016.10.019
Roy, 2006, Short-chain fatty acids: Ready for prime time?, Nutr. Clin. Pract., 21, 351, 10.1177/0115426506021004351
Sims, 2014, In vitro fermentation of prebiotic oligosaccharides by Bifidobacterium lactis HN019 and Lactobacillus spp., Anaerobe, 25, 11, 10.1016/j.anaerobe.2013.11.001
Andoh, 2016, Physiological role of gut microbiota for maintaining human health, Digestion, 93, 176, 10.1159/000444066
Ohira, 2017, Are short chain fatty acids in gut microbiota defensive players for inflammation and atherosclerosis?, J. Atheroscler. Thromb., 24, 660, 10.5551/jat.RV17006
Sivaprakasam, 2016, Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis, Pharmacol. Ther., 164, 144, 10.1016/j.pharmthera.2016.04.007
Morrison, 2016, Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism, Gut Microbes, 7, 189, 10.1080/19490976.2015.1134082
Bergman, 1990, Energy contributions of volatile fatty acids from the gastrointestinal tract in various species, Physiol. Rev., 70, 567, 10.1152/physrev.1990.70.2.567
Kim, 2014, Perspectives on the therapeutic potential of short-chain fatty acid receptors, BMB Rep., 47, 173, 10.5483/BMBRep.2014.47.3.272
Singh, 2014, Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis, Immunity, 40, 128, 10.1016/j.immuni.2013.12.007
Ang, 2016, GPR41 and GPR43 in obesity and inflammation—Protective or causative?, Front. Immunol., 7, 28, 10.3389/fimmu.2016.00028
Litvak, 2018, Colonocyte metabolism shapes the gut microbiota, Science, 362, eaat9076, 10.1126/science.aat9076
Haslam, 2018, Antibiotic exposure and reduced short chain fatty acid production after hematopoietic stem cell transplant, Biol. Blood Marrow Transpl., 24, 2418, 10.1016/j.bbmt.2018.07.030
Wassenaar, 2016, Insights from 100 years of research with probiotic E. coli, Eur. J. Microbiol. Immunol., 6, 147, 10.1556/1886.2016.00029
Byndloss, 2017, Microbiota-activated PPAR-gamma signaling inhibits dysbiotic Enterobacteriaceae expansion, Science, 357, 570, 10.1126/science.aam9949
Winter, 2013, Host-derived nitrate boosts growth of E. coli in the inflamed gut, Science, 339, 708, 10.1126/science.1232467
Xu, 2018, 5-Aminosalicylic acid alters the gut bacterial microbiota in patients with ulcerative colitis, Front. Microbiol., 9, 1274, 10.3389/fmicb.2018.01274
Pang, 2014, Fecal biomarkers of intestinal health and disease in children, Front. Pediatr., 2, 6, 10.3389/fped.2014.00006
Abdulamir, 2010, The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects, Open Biochem. J., 4, 53, 10.2174/1874091X01004010053
Sanchez, 2019, Faecal bacterial and short-chain fatty acids signature in hypercholesterolemia, Sci. Rep., 9, 1772, 10.1038/s41598-019-38874-3
Imperiale, 2019, Performance characteristics of fecal immunochemical tests for colorectal cancer and advanced adenomatous polyps: A systematic review and meta-analysis, Ann. Intern. Med., 170, 319, 10.7326/M18-2390
Lazaridis, 2018, Current insights into the innate immune system dysfunction in irritable bowel syndrome, Ann. Gastroenterol., 31, 171
Yao, 2012, Subtypes of irritable bowel syndrome on Rome III criteria: A multicenter study, J. Gastroenterol. Hepatol., 27, 760, 10.1111/j.1440-1746.2011.06930.x
Hughes, 2013, Immune activation in irritable bowel syndrome: Can neuroimmune interactions explain symptoms?, Am. J. Gastroenterol., 108, 1066, 10.1038/ajg.2013.120
Langhorst, 2009, Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome, Am. J. Gastroenterol., 104, 404, 10.1038/ajg.2008.86
Farup, P.G., Rudi, K., and Hestad, K. (2016). Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?. BMC Gastroenterol., 16.
Linsalata, M., Riezzo, G., D’Attoma, B., Clemente, C., Orlando, A., and Russo, F. (2018). Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: A case-control study. BMC Gastroenterol., 18.
Mu, 2017, Leaky gut as a danger signal for autoimmune diseases, Front. Immunol., 8, 598, 10.3389/fimmu.2017.00598
Briskey, 2016, Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease, Ther. Adv. Gastroenterol., 9, 463, 10.1177/1756283X16645055
Wang, 2016, Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation, Cell Host Microbe, 19, 227, 10.1016/j.chom.2016.01.003
Carabotti, 2015, The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems, Ann. Gastroenterol., 28, 203
Quigley, E.M.M. (2018). The gut-brain axis and the microbiome: Clues to pathophysiology and opportunities for novel management strategies in irritable bowel syndrome (IBS). J. Clin. Med., 7.
Strati, 2017, New evidences on the altered gut microbiota in autism spectrum disorders, Microbiome, 5, 24, 10.1186/s40168-017-0242-1
Fowlie, G., Cohen, N., and Ming, X. (2018). The perturbance of microbiome and gut-brain axis in autism spectrum disorders. Int. J. Mol. Sci., 19.
Francavilla, 2015, Autism spectrum disorders and intestinal microbiota, Gut Microbes, 6, 207, 10.1080/19490976.2015.1035855
Sinaiscalco, 2018, Autism and neuro-immune-gut link, AIMS Mol. Sci., 5, 166, 10.3934/molsci.2018.2.166
Reddel, S., Putignani, L., and Del Chierico, F. (2019). The impact of low-FODMAPs, gluten-free, and ketogenic diets on gut microbiota modulation in pathological conditions. Nutrients, 11.
Stafstrom, 2012, The ketogenic diet as a treatment paradigm for diverse neurological disorders, Front. Pharmacol., 3, 59, 10.3389/fphar.2012.00059
Olson, 2018, The gut microbiota mediates the anti-seizure effects of the ketogenic diet, Cell, 173, 1728, 10.1016/j.cell.2018.04.027
Wong, 2003, GABA, gamma-hydroxybutyric acid, and neurological disease, Ann. Neurol., 54, S3, 10.1002/ana.10696
Doenyas, 2018, Dietary interventions for autism spectrum disorder: New perspectives from the gut-brain axis, Physiol. Behav., 194, 577, 10.1016/j.physbeh.2018.07.014
Sampson, 2016, Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease, Cell, 167, 1469, 10.1016/j.cell.2016.11.018
Sarkar, 2016, Psychobiotics and the manipulation of bacteria-gut-brain signals, Trends Neurosci., 39, 763, 10.1016/j.tins.2016.09.002
Skonieczna-Zydecka, K., Marlicz, W., Misera, A., Koulaouzidis, A., and Loniewski, I. (2018). Microbiome-the missing link in the gut-brain axis: Focus on its role in gastrointestinal and mental health. J. Clin. Med., 7.
Cammarota, 2017, European consensus conference on faecal microbiota transplantation in clinical practice, Gut, 66, 569, 10.1136/gutjnl-2016-313017
Kang, 2017, Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study, Microbiome, 5, 10, 10.1186/s40168-016-0225-7
Choi, 2016, Fecal microbiota transplantation: Current applications, effectiveness, and future perspectives, Clin. Endosc., 49, 257, 10.5946/ce.2015.117
Frissen, 2017, Fecal microbiota transplantation in metabolic syndrome: History, present and future, Gut Microbes, 8, 253, 10.1080/19490976.2017.1293224
Kootte, 2017, Improvement of insulin sensitivity after lean donor feces in metabolic syndrome Is driven by baseline intestinal microbiota composition, Cell Metab., 26, 611, 10.1016/j.cmet.2017.09.008
Foster, 2013, Gut-brain axis: How the microbiome influences anxiety and depression, Trends Neurosci., 36, 305, 10.1016/j.tins.2013.01.005
Falony, 2019, The neuroactive potential of the human gut microbiota in quality of life and depression, Nat. Microbiol., 4, 623, 10.1038/s41564-018-0337-x
Wallace, 2017, The effects of probiotics on depressive symptoms in humans: A systematic review, Ann. Gen. Psychiatry, 16, 14, 10.1186/s12991-017-0138-2
Boehme, M., Van De Wouw, M., Bastiaanssen, T.F.S., Olavarria-Ramirez, L., Lyons, K., Fouhy, F., Golubeva, A.V., Moloney, G.M., Minuto, C., and Sandhu, K.V. (2019). Mid-life microbiota crises: Middle age is associated with pervasive neuroimmune alterations that are reversed by targeting the gut microbiome. Mol. Psychiatry, in press.
Banta, 2019, Mental health status and dietary intake among California adults: A population-based survey, Int. J. Food Sci. Nutr., 70, 759, 10.1080/09637486.2019.1570085
Sonnenburg, 2016, Diet-microbiota interactions as moderators of human metabolism, Nature, 535, 56, 10.1038/nature18846
Ridaura, 2013, Gut microbiota from twins discordant for obesity modulate metabolism in mice, Science, 341, 1241214, 10.1126/science.1241214
Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414
Turnbaugh, 2009, A core gut microbiome in obese and lean twins, Nature, 457, 480, 10.1038/nature07540
Nielsen, 2013, Richness of human gut microbiome correlates with metabolic markers, Nature, 500, 541, 10.1038/nature12506
Cotillard, 2013, Dietary intervention impact on gut microbial gene richness, Nature, 500, 585, 10.1038/nature12480
Everard, 2013, Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity, Proc. Natl. Acad. Sci. USA, 110, 9066, 10.1073/pnas.1219451110
Anhe, 2015, A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice, Gut, 64, 872, 10.1136/gutjnl-2014-307142
Dao, 2016, Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology, Gut, 65, 426, 10.1136/gutjnl-2014-308778
Depommier, 2019, Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study, Nat. Med., 25, 1096, 10.1038/s41591-019-0495-2
Zhai, Q., Feng, S., Arjan, N., and Chen, W. (2018). A next generation probiotic, Akkermansia muciniphila. Crit. Rev. Food Sci. Nutr., in press.
Liou, 2013, Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity, Sci. Transl. Med., 5, 178ra41, 10.1126/scitranslmed.3005687
Kasubuchi, 2015, Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation, Nutrients, 7, 2839, 10.3390/nu7042839
Zhang, 2009, Human gut microbiota in obesity and after gastric bypass, Proc. Natl. Acad. Sci. USA, 106, 2365, 10.1073/pnas.0812600106
Furet, 2010, Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and low-grade inflammation markers, Diabetes, 59, 3049, 10.2337/db10-0253
Jiao, A.R., Diao, H., Yu, B., He, J., Yu, J., Zheng, P., Huang, Z.Q., Luo, Y.H., Luo, J.Q., and Mao, X.B. (2018). Oral administration of short chain fatty acids could attenuate fat deposition of pigs. PLoS ONE, 13.
Canfora, 2017, Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: A randomized crossover trial, Sci. Rep., 7, 2360, 10.1038/s41598-017-02546-x
Chambers, 2018, Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health, Curr. Nutr. Rep., 7, 198, 10.1007/s13668-018-0248-8
Fernandes, 2014, Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans, Nutr. Diabetes, 4, e121, 10.1038/nutd.2014.23
Menni, 2017, Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain, Int. J. Obes., 41, 1099, 10.1038/ijo.2017.66
Li, 2018, Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit, Gut, 67, 1269, 10.1136/gutjnl-2017-314050
Roshanravan, 2017, Effect of butyrate and inulin supplementation on glycemic status, lipid profile and glucagon-like peptide 1 level in patients with type 2 diabetes: A randomized double-blind, placebo-controlled trial, Horm. Metab. Res., 49, 886, 10.1055/s-0043-119089
Sen, 2017, Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity, Physiol. Behav., 173, 305, 10.1016/j.physbeh.2017.02.027
Cani, 2007, Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes, 56, 1761, 10.2337/db06-1491
Boutagy, 2016, Metabolic endotoxemia with obesity: Is it real and is it relevant?, Biochimie, 124, 11, 10.1016/j.biochi.2015.06.020
Pedersen, 2016, Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake, Br. J. Nutr., 116, 1869, 10.1017/S0007114516004086
Cox, 2017, Increased intestinal permeability as a risk factor for type 2 diabetes, Diabetes Metab., 43, 163, 10.1016/j.diabet.2016.09.004
Colantonio, A.G., Werner, S.L., and Brown, M. (2019). The effects of prebiotics and substances with prebiotic properties on metabolic and inflammatory biomarkers in individuals with type 2 diabetes mellitus: A systematic review. J. Acad. Nutr. Diet., in press.
Dahl, 2017, Health benefits of fiber fermentation, J. Am. Coll. Nutr., 36, 127, 10.1080/07315724.2016.1188737
Weickert, 2018, Impact of dietary fiber consumption on insulin resistance and the prevention of type 2 diabetes, J. Nutr., 148, 7, 10.1093/jn/nxx008
Reynolds, 2019, Carbohydrate quality and human health: A series of systematic reviews and meta-analyses, Lancet, 393, 434, 10.1016/S0140-6736(18)31809-9
McKenzie, 2016, British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update), J. Hum. Nutr. Diet., 29, 549, 10.1111/jhn.12385
McRorie, 2015, Evidence-based approach to fiber supplements and clinically meaningful health benefits, Part 1: What to look for and how to recommend an effective fiber therapy, Nutr. Today, 50, 82, 10.1097/NT.0000000000000082
Lambeau, 2017, Fiber supplements and clinically proven health benefits: How to recognize and recommend an effective fiber therapy, J. Am. Assoc. Nurse Pract., 29, 216, 10.1002/2327-6924.12447
Jakobsdottir, G., Xu, J., Molin, G., Ahrne, S., and Nyman, M. (2013). High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PLoS ONE, 8.
Arora, 2019, Microbial fermentation of flaxseed fibers modulates the transcriptome of GPR41-expressing enteroendocrine cells and protects mice against diet-induced obesity, Am. J. Physiol. Endocrinol. Metab., 316, E453, 10.1152/ajpendo.00391.2018
Simpson, 2015, Review article: Dietary fibre-microbiota interactions, Aliment. Pharmacol. Ther., 42, 158, 10.1111/apt.13248
Zhernakova, 2016, Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity, Science, 352, 565, 10.1126/science.aad3369
Trompette, 2014, Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis, Nat. Med., 20, 159, 10.1038/nm.3444
Suez, 2014, Artificial sweeteners induce glucose intolerance by altering the gut microbiota, Nature, 514, 181, 10.1038/nature13793
Zeevi, 2015, Personalized nutrition by prediction of glycemic responses, Cell, 163, 1079, 10.1016/j.cell.2015.11.001
Azulay, 2019, Model of personalized postprandial glycemic response to food developed for an Israeli cohort predicts responses in Midwestern American individuals, Am. J. Clin. Nutr., 110, 63, 10.1093/ajcn/nqz028
Bashiardes, 2018, Towards utilization of the human genome and microbiome for personalized nutrition, Curr. Opin. Biotechnol., 51, 57, 10.1016/j.copbio.2017.11.013
Qin, 2012, A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, 490, 55, 10.1038/nature11450
Wu, 2017, Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug, Nat. Med., 23, 850, 10.1038/nm.4345
Bauer, 2018, Metformin alters upper small intestinal microbiota that impact a glucose-SGLT1-sensing glucoregulatory pathway, Cell Metab., 27, 101, 10.1016/j.cmet.2017.09.019
Mueller, 2017, Metformin Is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut, Diabetes Care, 40, 54, 10.2337/dc16-1324
Bryrup, 2019, Metformin-induced changes of the gut microbiota in healthy young men: Results of a non-blinded, one-armed intervention study, Diabetologia, 62, 1024, 10.1007/s00125-019-4848-7
Baxter, 2019, The glucoamylase inhibitor acarbose has a diet-dependent and reversible effect on the murine gut microbiome, mSphere, 4, e00528-18, 10.1128/mSphere.00528-18
Wang, 2011, Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease, Nature, 472, 57, 10.1038/nature09922
Gregory, 2015, Transmission of atherosclerosis susceptibility with gut microbial transplantation, J. Biol. Chem., 290, 5647, 10.1074/jbc.M114.618249
Tang, 2013, Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk, N. Engl. J. Med., 368, 1575, 10.1056/NEJMoa1109400
Senthong, 2016, Intestinal microbiota-generated metabolite trimethylamine-N-oxide and 5-year mortality risk in stable coronary artery disease: The contributory role of intestinal microbiota in a COURAGE-like patient cohort, J. Am. Heart Assoc., 5, e002816, 10.1161/JAHA.115.002816
Petersen, 2017, Healthy dietary patterns for preventing cardiometabolic disease: The role of plant-based foods and animal products, Curr. Dev. Nutr., 1, e001289, 10.3945/cdn.117.001289
Soliman, G.A. (2018). Dietary cholesterol and the lack of evidence in cardiovascular disease. Nutrients, 10.
Zhong, 2019, Associations of dietary cholesterol or egg consumption with incident cardiovascular disease and mortality, JAMA, 321, 1081, 10.1001/jama.2019.1572
Wang, 2015, Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis, Cell, 163, 1585, 10.1016/j.cell.2015.11.055
Chen, 2017, Gut microbiota-dependent metabolite trimethylamine N-oxide contributes to cardiac dysfunction in Western diet-induced obese mice, Front. Physiol., 8, 139, 10.3389/fphys.2017.00139
Rath, 2017, Uncovering the trimethylamine-producing bacteria of the human gut microbiota, Microbiome, 5, 54, 10.1186/s40168-017-0271-9
Koeth, 2013, Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis, Nat. Med., 19, 576, 10.1038/nm.3145
Koeth, 2019, L-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans, J. Clin. Investig., 129, 373, 10.1172/JCI94601
Alshahrani, S.M., Fraser, G.E., Sabate, J., Knutsen, R., Shavlik, D., Mashchak, A., Lloren, J.I., and Orlich, M.J. (2019). Red and processed meat and mortality in a low meat intake population. Nutrients, 11.
Bellavia, 2016, High red meat intake and all-cause cardiovascular and cancer mortality: Is the risk modified by fruit and vegetable intake?, Am. J. Clin. Nutr., 104, 1137, 10.3945/ajcn.116.135335
Micha, 2017, Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States, JAMA, 317, 912, 10.1001/jama.2017.0947
Micha, 2010, Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: A systematic review and meta-analysis, Circulation, 121, 2271, 10.1161/CIRCULATIONAHA.109.924977
Satija, 2019, Meta-analysis of randomized controlled trials of red meat consumption in comparison with various comparison diets on cardiovascular risk factors, Circulation, 139, 1828, 10.1161/CIRCULATIONAHA.118.035225
Hills, 2018, Guide to popular diets, food choices, and their health outcome, Health Care Curr. Rev., 6, 223
Jin, Q., Black, A., Kales, S.N., Vattem, D., Ruiz-Canela, M., and Sotos-Prieto, M. (2019). Metabolomics and microbiomes as potential tools to evaluate the effects of the Mediterranean diet. Nutrients, 11.
Lara, 2019, Dietary patterns and incident heart failure in U.S. adults without known coronary disease, J. Am. Coll. Cardiol., 73, 2036, 10.1016/j.jacc.2019.01.067
Grosso, 2017, A comprehensive meta-analysis on evidence of Mediterranean diet and cardiovascular disease: Are individual components equal?, Crit. Rev. Food Sci. Nutr., 57, 3218, 10.1080/10408398.2015.1107021
Pellegrini, 2016, High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome, Gut, 65, 1812, 10.1136/gutjnl-2015-309957
Alexander, 2015, Red meat and colorectal cancer: A quantitative update on the state of the epidemiologic science, J. Am. Coll. Nutr., 34, 521, 10.1080/07315724.2014.992553
Schwingshackl, L., Schwedhelm, C., Galbete, C., and Hoffmann, G. (2017). Adherence to Mediterranean Diet and risk of cancer: An updated systematic review and meta-analysis. Nutrients, 9.
Thomas, 2019, Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation, Nat. Med., 25, 667, 10.1038/s41591-019-0405-7
Wirbel, 2019, Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer, Nat. Med., 25, 679, 10.1038/s41591-019-0406-6
Youn, 2019, Association of choline and betaine levels with cancer incidence and survival: A meta-analysis, Clin. Nutr., 38, 100, 10.1016/j.clnu.2018.01.042
Bishehsari, F., Engen, P.A., Preite, N.Z., Tuncil, Y.E., Naqib, A., Shaikh, M., Rossi, M., Wilber, S., Green, S.J., and Hamaker, B.R. (2018). Dietary fiber treatment corrects the composition of gut microbiota, promotes SCFA production, and suppresses colon carcinogenesis. Genes, 9.
Song, 2015, Dietary fibre and the risk of colorectal cancer: A case- control study, Asian Pac. J. Cancer Prev., 16, 3747, 10.7314/APJCP.2015.16.9.3747
Zhang, 2019, Preventable cancer burden associated with poor diet in the United States, JNCI Cancer Spectr., 3, pkz034, 10.1093/jncics/pkz034
Vonaesch, 2018, Pathogens, microbiome and the host: Emergence of the ecological Koch’s postulates, FEMS Microbiol. Rev., 42, 273, 10.1093/femsre/fuy003
Tomkovich, 2019, Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic, J. Clin. Investig., 130, 1699, 10.1172/JCI124196
Hill, 2014, Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic, Nat. Rev. Gastroenterol. Hepatol., 11, 506, 10.1038/nrgastro.2014.66
Shen, 2014, Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn’s disease, and pouchitis: Meta-analysis of randomized controlled trials, Inflamm. Bowel Dis., 20, 21, 10.1097/01.MIB.0000437495.30052.be
Wilkins, 2017, Probiotics for gastrointestinal conditions: A summary of the evidence, Am. Fam. Physician, 96, 170
Tojo, 2014, Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis, World J. Gastroenterol., 20, 15163, 10.3748/wjg.v20.i41.15163
Sanchez, 2017, Probiotics, gut microbiota, and their influence on host health and disease, Mol. Nutr. Food Res., 61, 1600240, 10.1002/mnfr.201600240
Allen, 2010, Probiotics for treating acute infectious diarrhoea, Cochrane Database Syst. Rev., 11, CD003048
Goldenberg, 2017, Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children, Cochrane Database Syst. Rev., 12, CD006095
Goldenberg, 2018, Probiotics to prevent Clostridium difficile infection in patients receiving antibiotics, JAMA, 320, 499, 10.1001/jama.2018.9064
Fijan, 2014, Microorganisms with claimed probiotic properties: An overview of recent literature, Int. J. Env. Res. Public Health, 11, 4745, 10.3390/ijerph110504745
Dimidi, 2017, Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation, Adv. Nutr., 8, 484, 10.3945/an.116.014407
LeBlanc, 2017, Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria, Microb. Cell Fact., 16, 79, 10.1186/s12934-017-0691-z
Ford, 2014, Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: Systematic review and meta-analysis, Am. J. Gastroenterol., 109, 1547, 10.1038/ajg.2014.202
Biagi, 2011, Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome, Gastroenterology, 141, 1792, 10.1053/j.gastro.2011.07.043
2016, Bifidobacteria and their role as members of the human gut microbiota, Front. Microbiol., 7, 925
Giamarellos-Bourboulis, E.J., Pyleris, E., Barbatzas, C., Pistiki, A., and Pimentel, M. (2016). Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage. BMC Gastroenterol., 16.
Saffouri, 2019, Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders, Nat. Commun., 10, 2012, 10.1038/s41467-019-09964-7
2018, The unregulated probiotic market, Clin. Gastroenterol. Hepatol., 17, 809
Campana, 2017, Strain-specific probiotic properties of lactic acid bacteria and their interference with human intestinal pathogens invasion, Gut Pathog., 9, 12, 10.1186/s13099-017-0162-4
Wang, L., Hu, L., Xu, Q., Yin, B., Fang, D., Wang, G., Zhao, J., Zhang, H., and Chen, W. (2017). Bifidobacterium adolescentis exerts strain-specific effects on constipation induced by loperamide in BALB/c mice. Int. J. Mol. Sci., 18.
Conway, T., and Cohen, P.S. (2015). Commensal and pathogenic Escherichia coli metabolism in the gut. Microbiol. Spectr., 3.
Goswami, 2015, Coculture of Escherichia coli O157:H7 with a nonpathogenic E. coli strain increases toxin production and virulence in a germfree mouse model, Infect. Immun., 83, 4185, 10.1128/IAI.00663-15
Crook, 2019, Adaptive strategies of the candidate probiotic E. coli Nissle in the mammalian gut, Cell Host Microbe, 25, 499, 10.1016/j.chom.2019.02.005
Lerner, 2017, Potential effects of horizontal gene exchange in the human gut, Front. Immunol., 8, 1630, 10.3389/fimmu.2017.01630
Trinchieri, 2017, Efficacy and safety of a multistrain probiotic formulation depends from manufacturing, Front. Immunol., 8, 1474, 10.3389/fimmu.2017.01474
Hod, 2018, The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome, Neurogastroenterol. Motil., 30, e13456, 10.1111/nmo.13456
Lee, 2018, The therapeutic effect of a multistrain probiotic on diarrhea-predominant irritable bowel syndrome: A pilot study, Gastroenterol. Res. Pract., 2018, 8791916, 10.1155/2018/8791916
Plaza-Diaz, J., Ruiz-Ojeda, F.J., Vilchez-Padial, L.M., and Gil, A. (2017). Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases. Nutrients, 9.
Floch, 2015, Recommendations for probiotic use--2015 Update: Proceedings and consensus opinion, J. Clin. Gastroenterol., 49, S69, 10.1097/MCG.0000000000000420
Markowiak, P., and Slizewska, K. (2017). Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients, 9.
Hughes, 2017, Bifidobacterium breve reduces apoptotic epithelial cell shedding in an exopolysaccharide and MyD88-dependent manner, Open Biol., 7, 160155, 10.1098/rsob.160155
Lam, Y.Y., Ha, C.W., Campbell, C.R., Mitchell, A.J., Dinudom, A., Oscarsson, J., Cook, D.I., Hunt, N.H., Caterson, I.D., and Holmes, A.J. (2012). Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS ONE, 7.
Wang, 2011, Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury, Am. J. Pathol., 179, 2866, 10.1016/j.ajpath.2011.08.039
Reid, 2006, Probiotics to prevent the need for, and augment the use of, antibiotics, Can. J. Infect. Dis. Med. Microbiol., 17, 219, 10.1155/2006/934626
Sherman, 2005, Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements, Infect. Immun., 73, 5183, 10.1128/IAI.73.8.5183-5188.2005
Ferrario, 2014, Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults, J. Nutr., 144, 1787, 10.3945/jn.114.197723
Barbara, 2018, Probiotics in irritable bowel syndrome: Where are we?, Neurogastroenterol. Motil., 30, e13513, 10.1111/nmo.13513
Baxter, 2019, Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers, mBio, 10, e02566-18, 10.1128/mBio.02566-18
Ribeiro, 2017, Gut microbiota and probiotics: Focus on diabetes mellitus, Crit. Rev. Food Sci. Nutr., 57, 2296, 10.1080/10408398.2014.934438
Sanchez, 2014, Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women, Br. J. Nutr., 111, 1507, 10.1017/S0007114513003875
Sabico, 2018, Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: A randomized, double-blind, placebo-controlled trial, Clin. Nutr., 38, 1561, 10.1016/j.clnu.2018.08.009
Abildgaard, 2017, Probiotic treatment reduces depressive-like behaviour in rats independently of diet, Psychoneuroendocrinology, 79, 40, 10.1016/j.psyneuen.2017.02.014
Kadooka, 2013, Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial, Br. J. Nutr., 110, 1696, 10.1017/S0007114513001037
Kim, 2018, Lactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adults: A randomized, double-blind, placebo-controlled trial, J. Med. Food, 21, 454, 10.1089/jmf.2017.3937
Valcheva, 2016, Prebiotics: Definition and protective mechanisms, Best Pract. Res. Clin. Gastroenterol., 30, 27, 10.1016/j.bpg.2016.02.008
Nie, Y., Lin, Q., and Luo, F. (2017). Effects of non-starch polysaccharides on inflammatory bowel disease. Int. J. Mol. Sci., 18.
Gil, 2019, Effects of sweeteners on the gut microbiota: A review of experimental studies and clinical trials, Adv. Nutr., 10, S31, 10.1093/advances/nmy037
Leenen, 2007, Inulin and oligofructose in chronic inflammatory bowel disease, J. Nutr., 137, 2572S, 10.1093/jn/137.11.2572S
Musilova, 2015, Prebiotic effects of a novel combination of galactooligosaccharides and maltodextrins, J. Med. Food, 18, 685, 10.1089/jmf.2013.0187
Nicolucci, 2017, Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity, Gastroenterology, 153, 711, 10.1053/j.gastro.2017.05.055
Rios, 2019, Protective effect of prebiotic and exercise intervention on knee health in a rat model of diet-induced obesity, Sci. Rep., 9, 3893, 10.1038/s41598-019-40601-x
Chen, 2017, Fiber-utilizing capacity varies in Prevotella- versus Bacteroides-dominated gut microbiota, Sci. Rep., 7, 2594, 10.1038/s41598-017-02995-4
Thomas, 2018, What is the evidence for a role for diet and nutrition in osteoarthritis?, Rheumatology, 57, iv61, 10.1093/rheumatology/key011
Watson, 2018, A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota, Gut, 67, 1974, 10.1136/gutjnl-2017-314968
Costantini, L., Molinari, R., Farinon, B., and Merendino, N. (2017). Impact of omega-3 fatty acids on the gut microbiota. Int. J. Mol. Sci., 18.
Menni, 2017, Omega-3 fatty acids correlate with gut microbiome diversity and production of N-carbamylglutamate in middle aged and elderly women, Sci. Rep., 7, 11079, 10.1038/s41598-017-10382-2
Kim, 2019, Coffee consumption and all-cause and cause-specific mortality: A meta-analysis by potential modifiers, Eur. J. Epidemiol., 34, 731, 10.1007/s10654-019-00524-3
Falony, 2016, Population-level analysis of gut microbiome variation, Science, 352, 560, 10.1126/science.aad3503
Vandeputte, 2016, Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates, Gut, 65, 57, 10.1136/gutjnl-2015-309618
Tropini, 2018, Transient osmotic perturbation causes long-term alteration to the gut microbiota, Cell, 173, 1742, 10.1016/j.cell.2018.05.008
Lee, S.H., Yun, Y., Kim, S.J., Lee, E.J., Chang, Y., Ryu, S., Shin, H., Kim, H.L., Kim, H.N., and Lee, J.H. (2018). Association between cigarette smoking status and composition of gut microbiota: Population-based cross-sectional study. J. Clin. Med., 7.
Song, 2013, Cohabiting family members share microbiota with one another and with their dogs, eLife, 2, e00458, 10.7554/eLife.00458
Parajuli, 2018, Urbanization reduces transfer of diverse environmental microbiota indoors, Front. Microbiol., 9, 84, 10.3389/fmicb.2018.00084
Mahnert, 2019, Man-made microbial resistances in built environments, Nat. Commun., 10, 968, 10.1038/s41467-019-08864-0
Fragiadakis, 2019, Links between environment, diet, and the hunter-gatherer microbiome, Gut Microbes, 10, 216, 10.1080/19490976.2018.1494103
Fu, 2015, The gut microbiome contributes to a substantial proportion of the variation in blood lipids, Circ. Res., 117, 817, 10.1161/CIRCRESAHA.115.306807
Elshazly, 2013, Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: The VLDL-2 study (very large database of lipids), J. Am. Coll. Cardiol., 62, 1960, 10.1016/j.jacc.2013.07.045
Ravnskov, 2018, LDL-C does not cause cardiovascular disease: A comprehensive review of the current literature, Expert Rev. Clin. Pharmacol., 11, 959, 10.1080/17512433.2018.1519391
Wu, 2019, Age, sex, and cardiovascular risk attributable to lipoprotein cholesterol among chinese individuals with coronary artery disease: A case-control study, Metab. Syndr. Relat. Disord., 17, 223, 10.1089/met.2018.0067
Ference, 2017, Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel, Eur. Heart J., 38, 2459, 10.1093/eurheartj/ehx144
Kastelein, 2008, Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment, Circulation, 117, 3002, 10.1161/CIRCULATIONAHA.107.713438
Meeusen, 2016, Should apolipoprotein B replace LDL cholesterol as therapeutic targets are lowered?, Curr. Opin. Lipidol., 27, 359, 10.1097/MOL.0000000000000313
Greene, 2006, Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population, Nutr. Metab., 3, 6, 10.1186/1743-7075-3-6
Willeit, 2018, Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: Individual patient-data meta-analysis of statin outcome trials, Lancet, 392, 1311, 10.1016/S0140-6736(18)31652-0
Tsimikas, S., Gordts, P., Nora, C., Yeang, C., and Witztum, J.L. (2019). Statin therapy increases lipoprotein(a) levels. Eur. Heart J., in press.
Choi, 2010, Statins do not decrease small, dense low-density lipoprotein, Tex. Heart Inst. J., 37, 421
Magge, 2012, Low-FODMAP diet for treatment of irritable bowel syndrome, Gastroenterol. Hepatol., 8, 739
Skodje, 2018, Fructan, rather than gluten, induces symptoms in patients with self-reported non-Celiac gluten sensitivity, Gastroenterology, 154, 529, 10.1053/j.gastro.2017.10.040
Biesiekierski, 2013, No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates, Gastroenterology, 145, 320, 10.1053/j.gastro.2013.04.051
Fasano, 2015, Nonceliac gluten sensitivity, Gastroenterology, 148, 1195, 10.1053/j.gastro.2014.12.049
Halmos, E.P., and Gibson, P.R. (2019). Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome. J. Gastroenterol. Hepatol., in press.
Staudacher, H.M., Ralph, F.S.E., Irving, P.M., Whelan, K., and Lomer, M.C.E. (2019). Nutrient intake, diet quality, and diet diversity in irritable bowel syndrome and the impact of the low FODMAP diet. J. Acad. Nutr. Diet., in press.
Claesson, 2012, Gut microbiota composition correlates with diet and health in the elderly, Nature, 488, 178, 10.1038/nature11319
Halmos, 2015, Diets that differ in their FODMAP content alter the colonic luminal microenvironment, Gut, 64, 93, 10.1136/gutjnl-2014-307264
Dieterich, 2019, Influence of low FODMAP and gluten-free diets on disease activity and intestinal microbiota in patients with non-celiac gluten sensitivity, Clin. Nutr., 38, 697, 10.1016/j.clnu.2018.03.017
Kosinski, C., and Jornayvaz, F.R. (2017). Effects of ketogenic diets on cardiovascular risk factors: Evidence from animal and human studies. Nutrients, 9.
Ebbeling, 2018, Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: Randomized trial, BMJ, 363, k4583, 10.1136/bmj.k4583
Fung, 2011, Low-carbohydrate diet scores and risk of type 2 diabetes in men, Am. J. Clin. Nutr., 93, 844, 10.3945/ajcn.110.004333
Seidelmann, 2018, Dietary carbohydrate intake and mortality: A prospective cohort study and meta-analysis, Lancet Public Health, 3, e419, 10.1016/S2468-2667(18)30135-X
Swidsinski, 2017, Reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic diet, Front. Microbiol., 8, 1141, 10.3389/fmicb.2017.01141
Zhang, 2018, Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet, Epilepsy Res., 145, 163, 10.1016/j.eplepsyres.2018.06.015
Kearns, C.E., Apollonio, D., and Glantz, S.A. (2017). Sugar industry sponsorship of germ-free rodent studies linking sucrose to hyperlipidemia and cancer: An historical analysis of internal documents. PLoS Biol., 15.
Hoffmann, C., Dollive, S., Grunberg, S., Chen, J., Li, H., Wu, G.D., Lewis, J.D., and Bushman, F.D. (2013). Archaea and fungi of the human gut microbiome: Correlations with diet and bacterial residents. PLoS ONE, 8.
Samuel, 2006, A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism, Proc. Natl. Acad. Sci. USA, 103, 10011, 10.1073/pnas.0602187103
McNeil, 1984, The contribution of the large intestine to energy supplies in man, Am. J. Clin. Nutr., 39, 338, 10.1093/ajcn/39.2.338
Ghoshal, 2016, Irritable bowel syndrome, particularly the constipation-predominant form, involves an increase in Methanobrevibacter smithii, which is associated with higher methane production, Gut Liver, 10, 932, 10.5009/gnl15588
Suhr, 2017, Fungi in the healthy human gastrointestinal tract, Virulence, 8, 352, 10.1080/21505594.2016.1247140
Otasevic, 2018, The dietary modification and treatment of intestinal Candida overgrowth - a pilot study, J. Mycol. Med., 28, 623, 10.1016/j.mycmed.2018.08.002
Bertolini, M., Ranjan, A., Thompson, A., Diaz, P.I., Sobue, T., Maas, K., and Dongari-Bagtzoglou, A. (2019). Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection. PLoS Pathog., 15.
Cottier, 2015, MIG1 regulates resistance of Candida albicans against the fungistatic effect of weak organic acids, Eukaryot. Cell, 14, 1054, 10.1128/EC.00129-15
Allonsius, 2017, Interplay between Lactobacillus rhamnosus GG and Candida and the involvement of exopolysaccharides, Microb. Biotechnol., 10, 1753, 10.1111/1751-7915.12799
Haas, 1955, The treatment of celiac disease with the specific carbohydrate diet; report on 191 additional cases, Am. J. Gastroenterol., 23, 344
(2019, July 14). Breaking the Vicious Cycle and the Specific Carbohydrate Diet. Available online: www.breakingtheviciouscycle.info.
Gottschall, E. (1994). Breaking the Vicious Cycle: Intestinal Health Through Diet, Kirkton Press.
(2019, June 26). Nutrition in Immune Balance (NiMBAL)—Food Table. Available online: www.nimbal.org/legalillegal-food-list.
Kakodkar, 2015, The specific carbohydrate diet for inflammatory bowel disease: A case series, J. Acad. Nutr. Diet., 115, 1226, 10.1016/j.jand.2015.04.016
Chassaing, 2015, Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome, Nature, 519, 92, 10.1038/nature14232
Chassaing, 2017, Colonic microbiota encroachment correlates with dysglycemia in humans, Cell. Mol. Gastroenterol. Hepatol., 4, 205, 10.1016/j.jcmgh.2017.04.001
Miclotte, L., and Van De Wiele, T. (2019). Food processing, gut microbiota and the globesity problem. Crit. Rev. Food Sci. Nutr., 1–14. in press.
Li, 2017, Intermittent fasting promotes white adipose browning and decreases obesity by shaping the gut microbiota, Cell Metab., 26, 672, 10.1016/j.cmet.2017.08.019
Chevalier, 2015, Gut microbiota orchestrates energy homeostasis during cold, Cell, 163, 1360, 10.1016/j.cell.2015.11.004
Zarrinpar, 2014, Diet and feeding pattern affect the diurnal dynamics of the gut microbiome, Cell Metab., 20, 1006, 10.1016/j.cmet.2014.11.008
Cignarella, 2018, Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota, Cell Metab., 27, 1222, 10.1016/j.cmet.2018.05.006
Rangan, 2019, Fasting-mimicking diet modulates microbiota and promotes intestinal regeneration to reduce inflammatory bowel disease pathology, Cell Rep., 26, 2704, 10.1016/j.celrep.2019.02.019
Catterson, 2018, Short-term, intermittent fasting induces long-lasting gut health and TOR-independent lifespan extension, Curr. Biol., 28, 1714, 10.1016/j.cub.2018.04.015
Muccioli, 2010, The endocannabinoid system links gut microbiota to adipogenesis, Mol. Syst. Biol., 6, 392, 10.1038/msb.2010.46
Pesce, 2018, Endocannabinoids in the treatment of gasytrointestinal inflammation and symptoms, Curr. Opin. Pharmacol., 43, 81, 10.1016/j.coph.2018.08.009
De Filippis, D., Esposito, G., Cirillo, C., Cipriano, M., De Winter, B.Y., Scuderi, C., Sarnelli, G., Cuomo, R., Steardo, L., and De Man, J.G. (2011). Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. PLoS ONE, 6.
Uranga, 2018, Cannabinoid pharmacology and therapy in gut disorders, Biochem. Pharmacol., 157, 134, 10.1016/j.bcp.2018.07.048
2011, Obesity and cannabis use: Results from 2 representative national surveys, Am. J. Epidemiol., 174, 929, 10.1093/aje/kwr200
Cluny, N.L., Keenan, C.M., Reimer, R.A., Le Foll, B., and Sharkey, K.A. (2015). Prevention of diet-induced obesity effects on body weight and gut microbiota in mice treated chronically with delta9-tetrahydrocannabinol. PLoS ONE, 10.
Zhang, 2013, Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut microbiota, Antimicrob. Agents Chemother., 57, 3659, 10.1128/AAC.00670-13
Solomon, 2016, Effect of proton pump inhibitors and antibiotics on the gut microbiome of hospitalised older persons, J. Infect., 72, 498, 10.1016/j.jinf.2016.01.015
Blaser, 2016, Antibiotic use and its consequences for the normal microbiome, Science, 352, 544, 10.1126/science.aad9358
Su, 2018, Meta-analysis: Proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth, J. Gastroenterol., 53, 27, 10.1007/s00535-017-1371-9
Trifan, 2017, Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis, World J. Gastroenterol., 23, 6500, 10.3748/wjg.v23.i35.6500
Gregoire, 2018, Systematic review: Human gut dysbiosis induced by non-antibiotic prescription medications, Aliment. Pharmacol. Ther., 47, 332, 10.1111/apt.14451
Imhann, 2016, Proton pump inhibitors affect the gut microbiome, Gut, 65, 740, 10.1136/gutjnl-2015-310376
Bahr, 2015, Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children, Transl. Psychiatry, 5, e652, 10.1038/tp.2015.135
Flowers, 2017, Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort, Pharmacotherapy, 37, 261, 10.1002/phar.1890
Rogers, 2016, The influence of non-steroidal anti-inflammatory drugs on the gut microbiome, Clin. Microbiol. Infect., 22, 178, 10.1016/j.cmi.2015.10.003
Meng, J., Yu, H., Ma, J., Wang, J., Banerjee, S., Charboneau, R., Barke, R.A., and Roy, S. (2013). Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner. PLoS ONE, 8.
Sharon, 2019, Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice, Cell, 177, 1600, 10.1016/j.cell.2019.05.004
Martinez, 2014, Understanding gut microbiota in elderly’s health will enable intervention through probiotics, Benef. Microbes, 5, 235, 10.3920/BM2013.0079
Davenport, E.R., Mizrahi-Man, O., Michelini, K., Barreiro, L.B., Ober, C., and Gilad, Y. (2014). Seasonal variation in human gut microbiome composition. PLoS ONE, 9.
Armour, 2019, A metagenomic meta-analysis reveals functional signatures of health and disease in the human gut microbiome, mSystems, 4, e00332-18, 10.1128/mSystems.00332-18
Brunt, 2019, Suppression of the gut microbiome ameliorates age-related arterial dysfunction and oxidative stress in mice, J. Physiol., 597, 2361, 10.1113/JP277336
Smith, 2017, Regulation of life span by the gut microbiota in the short-lived African turquoise killifish, eLife, 6, e27014, 10.7554/eLife.27014
Tirosh, 2019, The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans, Sci. Transl. Med., 11, eaav0120, 10.1126/scitranslmed.aav0120
Perry, 2016, Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome, Nature, 534, 213, 10.1038/nature18309
Si, 2018, Gut microbiome-induced shift of acetate to butyrate positively manages dysbiosis in high fat diet, Mol. Nutr. Food Res., 62, 1700670, 10.1002/mnfr.201700670
Arrieta, 2018, Microbial eukaryotes: A missing link in gut microbiome studies, mSystems, 3, e00201-17, 10.1128/mSystems.00201-17
Rampelli, 2017, Characterization of the human DNA gut virome across populations with different subsistence strategies and geographical origin, Environ. Microbiol., 19, 4728, 10.1111/1462-2920.13938
Hsu, 2019, Dynamic modulation of the gut microbiota and metabolome by bacteriophages in a mouse model, Cell Host Microbe, 25, 803, 10.1016/j.chom.2019.05.001
Norman, 2015, Disease-specific alterations in the enteric virome in inflammatory bowel disease, Cell, 160, 447, 10.1016/j.cell.2015.01.002
Audebert, 2016, The Blastocystis Investigation Group; Loywick, A.; Merlin, S.; Viscogliosi, E.; Chabe, M. Colonization with the enteric protozoa Blastocystis is associated with increased diversity of human gut bacterial microbiota, Sci. Rep., 6, 25255, 10.1038/srep25255
Poirier, P., Wawrzyniak, I., Vivares, C.P., Delbac, F., and El Alaoui, H. (2012). New insights into Blastocystis spp.: A potential link with irritable bowel syndrome. PLoS Pathog., 8.
Yason, 2019, Interactions between a pathogenic Blastocystis subtype and gut microbiota: In vitro and in vivo studies, Microbiome, 7, 30, 10.1186/s40168-019-0644-3
Reynolds, 2018, Asymptomatic intestinal colonization with protist Blastocystis is strongly associated with distinct microbiome ecological patterns, mSystems, 3, e00007-18, 10.1128/mSystems.00007-18
Gentekaki, E., Curtis, B.A., Stairs, C.W., Klimes, V., Elias, M., Salas-Leiva, D.E., Herman, E.K., Eme, L., Arias, M.C., and Henrissat, B. (2017). Extreme genome diversity in the hyper-prevalent parasitic eukaryote Blastocystis. PLoS Biol., 15.
Zmora, 2019, You are what you eat: Diet, health and the gut microbiota, Nat. Rev. Gastroenterol. Hepatol., 16, 35, 10.1038/s41575-018-0061-2
Chen, 2019, Association among dietary supplement use, nutrient intake, and mortality among U.S. adults: A cohort study, Ann. Intern. Med., 170, 604, 10.7326/M18-2478
Fetissov, 2017, Role of the gut microbiota in host appetite control: Bacterial growth to animal feeding behaviour, Nat. Rev. Endocrinol., 13, 11, 10.1038/nrendo.2016.150
Thorburn, 2014, Diet, metabolites, and “Western-lifestyle” inflammatory diseases, Immunity, 40, 833, 10.1016/j.immuni.2014.05.014
Vieira-Silva, S., Sabino, J., Valles-Colomer, M., Falony, G., Kathagen, G., Caenepeel, C., Cleynen, I., Van Der Merwe, S., Vermeire, S., and Raes, J. (2019). Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses. Nat. Microbiol., in press.
Hillman, 2017, Microbial ecology along the gastrointestinal tract, Microbes Environ., 32, 300, 10.1264/jsme2.ME17017
Estelle, 2018, Characterization of bacterial microbiota compositions along the intestinal tract in pigs and their interactions and functions, Sci. Rep., 8, 12727, 10.1038/s41598-018-30932-6
Johnson, 2019, Daily sampling reveals personalized diet-microbiome associations in humans, Cell Host Microbe, 25, 789, 10.1016/j.chom.2019.05.005
David, 2014, Diet rapidly and reproducibly alters the human gut microbiome, Nature, 505, 559, 10.1038/nature12820
Zimmermann, 2019, Mapping human microbiome drug metabolism by gut bacteria and their genes, Nature, 570, 462, 10.1038/s41586-019-1291-3
De Toro-Martin, J., Arsenault, B.J., Despres, J.P., and Vohl, M.C. (2017). Precision nutrition: A review of personalized nutritional approaches for the prevention and management of metabolic syndrome. Nutrients, 9.